Lucerna, Inc., founded in 2010 and based in New York, is a biotechnology company dedicated to advancing RNA imaging and drug discovery. The company's core mission is to lead the market in developing RNA-based research reagents, leveraging their proprietary fluorescent aptamer technology, Spinach™. Lucerna's products include plug-and-play RNA imaging systems and high-throughput screening platforms designed to accelerate medical research and drug development.
Notable figures affiliated with Lucerna include leading scientists in the field of RNA research. The company has attracted significant investment from prominent biotech venture capital firms. Key achievements include the successful commercialization of their Spinach™ technology and the development of innovative drug discovery platforms. Lucerna's impact is evident in its contribution to accelerating RNA-focused research, providing essential tools that enhance the understanding and treatment of various diseases.
